Literature DB >> 2779536

L-propionyl-carnitine protection of mitochondria in ischemic rat hearts.

F Di Lisa1, R Menabò, N Siliprandi.   

Abstract

The energy-linked processes (transmembrane potential and oxidative phosphorylation) resulted in impaired mitochondria isolated from ischemic perfused rat hearts. Addition of 1.5 mM L-propionyl-carnitine to the perfusate significantly reduced the ischemic damage and ameliorated mitochondrial Ca2+ homeostasis. In both normoxic and ischemic hearts perfused with L-propionyl-carnitine a consistent amount of propionyl-CoA-otherwise undetectable-was produced. L-propionyl-carnitine treatment also prevented the decrease of succinyl-CoA associated with the ischemic condition. These results and the decrease of myocardial acetyl-CoA induced by exogenous L-propionyl-carnitine points to the anaplerotic effect of this ester. The consequently improved flux in the tricarboxylic-acid cycle may account for the observed protection of mitochondrial functions afforded by L-propionyl-carnitine in the ischemic perfused hearts.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2779536     DOI: 10.1007/BF00223439

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  16 in total

1.  Determination of serum proteins by means of the biuret reaction.

Authors:  A G GORNALL; C J BARDAWILL; M M DAVID
Journal:  J Biol Chem       Date:  1949-02       Impact factor: 5.157

2.  Isovalerylcarnitine is a specific activator of calpain of human neutrophils.

Authors:  S Pontremoli; E Melloni; M Michetti; B Sparatore; F Salamino; N Siliprandi; B L Horecker
Journal:  Biochem Biophys Res Commun       Date:  1987-11-13       Impact factor: 3.575

3.  Reevaluation of oxidative phosphorylation in cardiac mitochondria from normal animals and animals in heart failure.

Authors:  G E Lindenmayer; L A Sordahl; A Schwartz
Journal:  Circ Res       Date:  1968-09       Impact factor: 17.367

4.  Anaerobic rat heart. Effects of glucose and tricarboxylic acid-cycle metabolites on metabolism and physiological performance.

Authors:  D G Penney; J Cascarano
Journal:  Biochem J       Date:  1970-06       Impact factor: 3.857

Review 5.  Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart.

Authors:  A J Liedtke
Journal:  Prog Cardiovasc Dis       Date:  1981 Mar-Apr       Impact factor: 8.194

6.  Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state.

Authors:  N Kamo; M Muratsugu; R Hongoh; Y Kobatake
Journal:  J Membr Biol       Date:  1979-08       Impact factor: 1.843

Review 7.  Carnitine: metabolism and clinical chemistry.

Authors:  N Siliprandi; L Sartorelli; M Ciman; F Di Lisa
Journal:  Clin Chim Acta       Date:  1989-07-31       Impact factor: 3.786

8.  Stimulation of oxidation of mitochondrial fatty acids and of acetate by acetylcarnitine.

Authors:  N Siliprandi; D Siliprandi; M Ciman
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

9.  Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation.

Authors:  D J Paulson; J Traxler; M Schmidt; J Noonan; A L Shug
Journal:  Cardiovasc Res       Date:  1986-07       Impact factor: 10.787

10.  Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts.

Authors:  A J Liedtke; L DeMaison; S H Nellis
Journal:  Am J Physiol       Date:  1988-07
View more
  14 in total

1.  Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat.

Authors:  T L Broderick; W Driedzic; D J Paulson
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

2.  Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart.

Authors:  R Ferrari; E Pasini; E Condorelli; A Boraso; R Lisciani; A Marzo; O Visiou
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

Review 3.  Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism.

Authors:  N Siliprandi; F Di Lisa; R Menabò
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

Review 4.  Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention.

Authors:  L G Spagnoli; A Mauriello; A Orlandi; G Sangiorgi; E Bonanno
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

Review 5.  Mitochondrial energy production and cation control in myocardial ischaemia and reperfusion.

Authors:  R Ferrari; P Pedersini; M Bongrazio; G Gaia; P Bernocchi; F Di Lisa; O Visioli
Journal:  Basic Res Cardiol       Date:  1993 Sep-Oct       Impact factor: 17.165

Review 6.  Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective.

Authors:  Andrew A Wolff; Heschi H Rotmensch; William C Stanley; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

7.  Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy.

Authors:  G L Bartels; W J Remme; F R den Hartog; R P Wielenga; D A Kruijssen
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

8.  Effect of pyruvate on rat heart thiol status during ischemia and hypoxia followed by reperfusion.

Authors:  M P Rigobello; A Bindoli
Journal:  Mol Cell Biochem       Date:  1993-05-26       Impact factor: 3.396

9.  Assessment of the cardiostimulant action of propionyl-L-carnitine on chronically volume-overloaded rat hearts.

Authors:  Z el Alaoui-Talibi; N Bouhaddioni; J Moravec
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

10.  Effect of propionyl-L-carnitine in a rat model of peripheral arteriopathy: a functional, histologic, and NMR spectroscopic study.

Authors:  N Corsico; A Nardone; M R Lucreziotti; L G Spagnoli; D Pesce; T Aureli; M E Di Cocco; A Miccheli; F Conti; E Arrigoni Martelli
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.